Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
€
2.42
Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab quantity
Add to cart
SKU:
product-article-16322
Category:
General
Description
Description
PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
Related products
Article: Highlights in squamous cell carcinoma of the head and neck
€
2.42
Add to cart
Article: INTRODUCTION
€
2.42
Add to cart
Article: Highlights in gynaecological cancers
€
2.42
Add to cart
Article: Highlights in urologic cancer
€
2.42
Add to cart